by Hermeet Suri | Aug 25, 2012 | News and Press
In June 2009, Genentech, Inc. withdrew the psoriasis drug Raptiva from the market after it was linked to deaths of at least three patients from a rare but often fatal brain disease, progressive multifocal leukoencephalopathy (PML). Although 80% of people are said...
by Hermeet Suri | Jul 13, 2012 | Latest Health News and Information
In June 2009, Genentech, Inc. withdrew the psoriasis drug Raptiva from the market after it was linked to deaths of at least three patients from a rare but often fatal brain disease, progressive multifocal leukoencephalopathy (PML). Although 80% of people are said...
Recent Comments